(Fortune) -- Pfizer (Charts) ranks no. 101 on FORTUNE's Global 500 this year, with $51.4 billion in revenues, down 3% from the previous year. The New York, New York-based company was ranked no. 75 on the 2005 list. Its 2005 profits were $8.1 billion, down 28.8% from a year earlier. 2005 was a banner year for most Global 500 companies.

It took $13.7 billion in revenue just to make this year's list - up from $12.4 billion last year. And profits for the 500 companies jumped 30%. Total revenues for the Global 500 in 2006 add up to $18.9 trillion, a third of the world's GDP. In the Pharmaceuticals industry, profits were up 8.1% from the previous year.

The world's biggest companies in the sector are: Johnson & Johnson (Charts), ranked no. 104 on the Global 500 with $50.5 billion in revenues; GlaxoSmithKline (Charts), ranked no. 143 on the Global 500 with $39.4 billion in revenues; Sanofi-Aventis (Charts), ranked no. 159 on the Global 500 with $35.4 billion in revenues; and Novartis Group (Charts), ranked no. 177 on the Global 500 with $32.2 billion in revenues.

The Global 500 list is an annual ranking of the world's largest corporations by revenues.

Next: Full list: 2006 Global 500 at http://money.cnn.com/magazines/fortune/global500/2006/index.html

Plus: See Pfizer's Global 500 details, including financial stats and contact information.